Glaukos Corp
NYSE:GKOS
Glaukos Corp
NYSE:GKOS
Price:
97.79
USD
-4.93%
Market Closed
Market Cap:
$5.7B
Relative Value
The Relative Value of one
GKOS
stock under the Base Case scenario is
50.4
USD.
Compared to the current market price of 97.79 USD,
Glaukos Corp
is
Overvalued by 48%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GKOS
Relative Value
Base Case
50.4
USD
Overvaluation 48%
Multiples Across Competitors
GKOS Competitors Multiples
Glaukos Corp Competitors
Glaukos Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Glaukos Corp
NYSE:GKOS
|
5.6B USD | 11.1 | -30 | -122 | -62.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
187.8B USD | 4.2 | 28.8 | 16.5 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.2B USD | 16.9 | 59.6 | 45.2 | 55.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129B USD | 5.1 | 39.7 | 20.3 | 24.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 3.2 | 24.3 | 13.4 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.7B USD | 5.1 | 35.1 | 20.6 | 27.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 1.9 | 20.6 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.1B USD | 8.1 | 45.8 | 25.2 | 27.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.6 | 43 | 30.6 | 33.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.5B USD | 2.1 | 25.9 | 10.2 | 17.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.9B USD | 6.3 | 22.8 | 16 | 17.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
